FARMACEUTSKE KOMBINACIJE KOJE OBUHVATAJU B-RAF INHIBITOR, EGFR INHIBITOR I OPCIONO PI3K-ALFA INHIBITOR

• 收藏
• 分享

专利权人:

NOVARTIS AG

发明人:

CAPONIGRO, GIORDANO,STUART, DARRIN,MOUTOUH-DE PARSEVAL, LAURE

申请号：

RSP20190351

公开号：

RS58734B1

申请日:

2013.08.05

申请国别(地区):

RS

年份:

2019

代理人:

摘要：

A pharmaceutical combination comprising (a) a B-Raf inhibitor, (b) a EGFR inhibitor and, optionally, (c) a PI3K inhibitor； the uses of such combination in the treatment of proliferative diseases； and methods of treating a subject suffering from a proliferative disease comprising administering a therapeutically effective amount of such combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/